FIELD: medicine.
SUBSTANCE: invention relates to a method of treating infections Helicobacter pylori (H. Pylori). For the treatment of infection Helicobacter pylori (H. pylori) a compound of formula (I) is administered to the individual in an amount effective to inhibit growth H. pylori, where formula (I) represents
(I),
where R represents Q or CH2SQ, where Q represents C1–C9-alkyl, aryl, heteroaryl, aralkyl or C4–C7 cycloalkyl, and wherein Q is optionally substituted with one or more selected from halogen, OH and/or NH2-groups, or a pharmaceutically acceptable salt or ester thereof.
EFFECT: invention makes it possible to increase the effectiveness of the fight against infection.
25 cl, 1 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TRICYCLIC PYRROLE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND USE THEREOF AS KINASE INHIBITORS | 2012 |
|
RU2591191C2 |
| MACROHETEROCYCLIC COMPOUNDS | 2001 |
|
RU2275373C2 |
| METHOD OF PRODUCTION OF NUCLEOSIDE PHOSPHORYLASE AND NUCLEOSIDASE INHIBITORS | 2004 |
|
RU2334757C2 |
| 6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEINKINASE INHIBITORS | 2005 |
|
RU2379308C2 |
| RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
| SELECTIVE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2011 |
|
RU2609210C2 |
| PYRROLE AND PYRAZOLE DAAO INHIBITORS | 2004 |
|
RU2361862C2 |
| SUBSTITUTED PYRROLES ACTIVE AS KINASES INHIBITORS | 2013 |
|
RU2666538C2 |
| PYRROLOPYRIDINES EFFECTIVE AS PROTEINKINASE INHIBITORS | 2006 |
|
RU2435769C2 |
| HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS | 2010 |
|
RU2615130C2 |
